About Index Trending news
Analyze
Top 50 Pricing
Psioxus Therapeutics

Psioxus Therapeutics

Work at Psioxus Therapeutics? Add yourself to this profile

Psioxus Therapeutics

Immuno-oncology specialists with a clinical stage oncolytic virus program and the T-SIGn plaform for immuno-gene-therapy

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series C)
$39,241,539
Venture capital (Series B)
$34,118,753
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Psioxus Therapeutics makes some noise.